C4 Therapeutics, Inc.
NASDAQ:CCCCBiotechnology
Healthcare
$2.48 +2.06%
+$0.08 today
- Market cap
- $325.01M
- Beta
- 2.93
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$0.82
52W Low $1.36High $4.60
Volume 2.75M
Average 2.76M
Price history
C4 Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-1.00%
Period high
$4.67
Period low
$1.71
Latest
$2.48
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 4 | Nov 13, 2026 | Nov 13, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 8-K | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 21, 2026 | Sep 21, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| SC 13G | Jul 27, 2026 | Jul 27, 2026 | |
| 4 | Jul 13, 2026 | Jul 13, 2026 |
Competitors
Who does C4 Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about CCCC's filings, answered from its disclosures.
What is the latest CCCC filing?
The latest filing shown is 4 dated Nov 13, 2026.
How many recent filings does CCCC have?
Intrinsic Alpha currently shows 20 recent filings for CCCC.
Continue the stock analysis
Jump to another research area for this company.